Clinical trial
Hypercoagulability After Breast Cancer Surgery
NCT00210197 · Institut Bergonié, Other · Completed
Key facts
| NCT number | NCT00210197 |
|---|---|
| Title | Hypercoagulability After Breast Cancer Surgery |
| Official title | Plasma Coagulation Parameters and Hypercoagulability After Breast Cancer Surgery |
| Acronym | EHC |
| Lead sponsor | Institut Bergonié, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer, Blood Coagulation Disorders |
| Intervention type | Procedure |
| Interventions | Blood collection (pre and postoperative): plasma coagulation parameters |
| Enrollment | 48 |
| Start date | Jan 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 26, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: